<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Expression of P-<z:chebi fb="2" ids="17089">glycoprotein</z:chebi> (P-gp) mediated multidrug resistance (<z:chebi fb="14" ids="53218">MDR</z:chebi>) has been suggested to be associated with an impaired clinical outcome in several <z:e sem="disease" ids="C0006826" disease_type="Neoplastic Process" abbrv="">malignancies</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>In contrast to P-gp itself, further phenotypical and functional alterations related to <z:chebi fb="14" ids="53218">MDR</z:chebi> are poorly characterized </plain></SENT>
<SENT sid="2" pm="."><plain>In this in vitro study, we analyzed two Burkitt's <z:hpo ids='HP_0002665'>lymphoma</z:hpo> cell lines (Raji and Daudi) for the beta 1 integrin phenotype prior to and after induction of <z:chebi fb="14" ids="53218">MDR</z:chebi> via co-cultivation with <z:chebi fb="0" ids="28445">vincristine</z:chebi> </plain></SENT>
<SENT sid="3" pm="."><plain>A significant loss of the VLA-3 (CD49c/CD29) <z:e sem="disease" ids="C0001511" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">adhesion</z:e> receptor was observed whereas <z:hpo ids='HP_0000001'>all</z:hpo> other intergins analyzed lacked considerable changes </plain></SENT>
<SENT sid="4" pm="."><plain>We conclude that induction of P-gp mediated <z:chebi fb="14" ids="53218">MDR</z:chebi> does not only affect resistance to cytotoxic drugs but also induces cellular changes with potential relevance for migratory and/or adhesive properties of malignant cells </plain></SENT>
</text></document>